October 14, 2015 Andrew M. Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G, Hubert H. Humphrey Building 200 Independence Ave., S.W. Washington, D.C. … [Read more...] about CMA Comments on Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities
Search Results for: oral health
2016 National Voices of Medicare Summit
and Senator Jay Rockefeller Lecture
On April 1, 2016, the Center for Medicare Advocacy held its third annual National Voices of Medicare Summit and Senator Jay Rockefeller Lecture. The event brought together leading experts and advocates to discuss best practices, challenges, … [Read more...] about 2016 National Voices of Medicare Summit
and Senator Jay Rockefeller Lecture
Proposed Requirements of Participation for Nursing Facilities Do Not Strengthen Standards for Residents
On July 13, 2015, the Centers for Medicare & Medicaid Services (CMS) posted proposed regulations to revise the Requirements of Participation for nursing homes (called Skilled Nursing Facilities under Medicare and Nursing Facilities under … [Read more...] about Proposed Requirements of Participation for Nursing Facilities Do Not Strengthen Standards for Residents
Center Comments to Senate Finance Committee Regarding Chronic Care Reform
June 22, 2015 The Honorable Orrin Hatch The Honorable Ron Wyden Chair, Committee on Finance … [Read more...] about Center Comments to Senate Finance Committee Regarding Chronic Care Reform
Has CMS’s Partnership with the Nursing Home Industry Really Reduced the Inappropriate Use of Antipsychotic Drugs by Nursing Home Residents as Much as CMS Claims? No.
In September 2014, the Centers for Medicare & Medicaid Services (CMS)[1] reported that the National Partnership to Improve Dementia Care had reduced the use of antipsychotic drugs with nursing home residents by 15.1%, “exceeding” the … [Read more...] about Has CMS’s Partnership with the Nursing Home Industry Really Reduced the Inappropriate Use of Antipsychotic Drugs by Nursing Home Residents as Much as CMS Claims? No.
The President’s Proposed FY 2016 Budget: The Impact on Medicare
On Monday, February 2nd, President Obama unveiled his Fiscal Year 2016 Budget.[1] For an overview of the budget’s Medicare-related provisions, including both projected costs and savings to the Medicare program, see the Kaiser Family … [Read more...] about The President’s Proposed FY 2016 Budget: The Impact on Medicare
50 Insights for Medicare’s 50th Anniversary
As part of our recognition of Medicare’s first 50 years, this week begins our Medicare Matters: 50 Insights for Medicare’s 50th Anniversary. Help us spread the word – on Twitter, Facebook – in … [Read more...] about 50 Insights for Medicare’s 50th Anniversary
December 2013 – Improvement Standard Update: CMS Issues Manual Provisions Pursuant to Jimmo, and Other Issues
1. PRESENTATION: CMS MANUAL PROVISIONS ISSUED PURSUANT TO THE JIMMO SETTLEMENT The Center for Medicare Advocacy is pleased to announce that the Medicare Policy Manuals have been revised pursuant to the Jimmo vs. Sebelius Settlement. … [Read more...] about December 2013 – Improvement Standard Update: CMS Issues Manual Provisions Pursuant to Jimmo, and Other Issues
Dual Eligible Special Needs Plans: Considerations for Reauthorization
Dual Eligible Special Needs Plans (D-SNPs) are a type of Medicare Advantage (MA) plan that enrolls only individuals dually eligible for Medicare and Medicaid. Though results have been mixed, D-SNPs were created as a possible route to better … [Read more...] about Dual Eligible Special Needs Plans: Considerations for Reauthorization
Examining Inappropriate Use of Antipsychotic Drugs, Part Two: How Surveyors Describe How, When, and Why They Cite Antipsychotic Drug Deficiencies (Note: Nearly 200 pages)
Examining Inappropriate Use of Antipsychotic Drugs, a Report in three Parts, looks at antipsychotic drug use in skilled nursing facilities (SNFs) and nursing facilities (NFs) from two perspectives. First, it analyzes the antipsychotic drug … [Read more...] about Examining Inappropriate Use of Antipsychotic Drugs, Part Two: How Surveyors Describe How, When, and Why They Cite Antipsychotic Drug Deficiencies (Note: Nearly 200 pages)